FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
-
Published:2020
Issue:6
Volume:5
Page:e000944
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Aranda EnriqueORCID,
Viéitez Jose Maria,
Gómez-España Auxiliadora,
Gil Calle Silvia,
Salud-Salvia Antonieta,
Graña Begoña,
Garcia-Alfonso PilarORCID,
Rivera Fernando,
Quintero-Aldana Guillermo Alfonso,
Reina-Zoilo Juan José,
González-Flores Encarnación,
Salgado Fernández Mercedes,
Guillén‑Ponce CarmenORCID,
Garcia-Carbonero Rocio,
Safont María José,
La Casta Munoa Adelaida,
García-Paredes Beatriz,
López López Rafael,
Sastre Javier,
Díaz-Rubio Eduardo
Subject
Cancer Research,Oncology
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献